Overview A Study of DS-9606a in Patients With Advanced Solid Tumors Status: Not yet recruiting Trial end date: 2023-11-30 Target enrollment: Participant gender: Summary This study will assess the safety and tolerability of DS-9606a in patients with advanced solid tumors. Phase: Phase 1 Details Lead Sponsor: Daiichi Sankyo, Inc.